Luke Wiegand (@wiegand_luke) 's Twitter Profile
Luke Wiegand

@wiegand_luke

Reconstructive Urology, Robotic Surgery - Orlando Health

ID: 3347632241

linkhttp://flgurecon.com calendar_today27-06-2015 15:18:55

990 Tweet

639 Followers

301 Following

Michael Fralick (@fralickmike) 's Twitter Profile Photo

Need a power/sample size calculation for a study or upcoming grant? Led by Emil Hodzic-Santor, we built a simple, free, and pain-free (!) shiny app. feedback welcome plz share with interested parties. check it out: powercalc.ca 🦾🤓 Michelle Sholzberg Kieran Campbell Lianne Jeffs

Need a power/sample size calculation for a study or upcoming grant? Led by <a href="/emil_hs/">Emil Hodzic-Santor</a>,  we built a simple, free, and pain-free (!) shiny app. feedback welcome plz share with interested parties. check it out: powercalc.ca 🦾🤓

<a href="/sholzberg/">Michelle Sholzberg</a> <a href="/kieranrcampbell/">Kieran Campbell</a> <a href="/JeffsLianne/">Lianne Jeffs</a>
UroToday.com (@urotoday) 's Twitter Profile Photo

This systematic review identifies key genomic risk factors for #UrethralStricture, revealing downregulation of CXCR3 and NOS2, and upregulation of TGFB1, UPK3A, and CTGF in affected tissues. Notably, PI3K and TGF-β1/SMAD pathways are linked to these changes. These insights could

This systematic review identifies key genomic risk factors for #UrethralStricture, revealing downregulation of CXCR3 and NOS2, and upregulation of TGFB1, UPK3A, and CTGF in affected tissues. Notably, PI3K and TGF-β1/SMAD pathways are linked to these changes. These insights could
Muhammad Ghanem, MD, FACS, FASMBS, DABOM (@muhammadghane19) 's Twitter Profile Photo

Amazing day at Orlando Health ! We performed the first magnetic anastomosis in the US while maintaining bowel continuity as part of the FLOWS FDA trial! Excited to be part of our amazing crew Manoel Galvao Neto MD, MSC, FASGE, IFASBMS @hany_takla3 Andre Teixeira

Amazing day at <a href="/orlandohealth/">Orlando Health</a> ! We performed the first magnetic anastomosis in the US while maintaining bowel continuity as part of the FLOWS FDA trial! Excited to be part of our amazing crew <a href="/MPGN46/">Manoel Galvao Neto MD, MSC, FASGE, IFASBMS</a> @hany_takla3 Andre Teixeira
Luke Wiegand (@wiegand_luke) 's Twitter Profile Photo

apple.news/AAKeLH3UuTlezZ… I offered my services to NASA for the Mars missions, but I was not accepted. 😢Maybe Elon Musk will put a #urologist on board.

Mutahar Ahmed (@roboticsurology) 's Twitter Profile Photo

nytimes.com/2024/10/08/wel…. I routinely use it in my complicated recon cases reducing need for buccal graft as well as in select RALP cases for nerve wrap

Crémieux (@cremieuxrecueil) 's Twitter Profile Photo

I simulated 100,000 people to show how often people are "thrice-exceptional": Smart, stable, and exceptionally hard-working. I've highlighted these people in red in this chart:

I simulated 100,000 people to show how often people are "thrice-exceptional": Smart, stable, and exceptionally hard-working.

I've highlighted these people in red in this chart:
Luke Wiegand (@wiegand_luke) 's Twitter Profile Photo

clinicaltrials.gov/study/NCT05383… Please check out this multi-instituional study looking at semen parameters after Optilume urethra. Still recruiting!! #urethralstricture #optilume Optilume

Optilume (@optilumedcb) 's Twitter Profile Photo

📊 Optilume® vs. DVIU: A New Standard in Stricture Treatment 🔹 Freedom from repeat intervention: ✔️ 1 year: Optilume® 83% 🆚 DVIU 21% ✔️ 2 years: Optilume® 80% 🆚 DVIU 0% ✔️ 5 years: Optilume® 72% Minimally invasive. Drug-coated. Clinically proven. 💡 Learn more &

📊 Optilume® vs. DVIU: A New Standard in Stricture Treatment 

🔹 Freedom from repeat intervention: 
✔️ 1 year: Optilume® 83% 🆚 DVIU 21% 
✔️ 2 years: Optilume® 80% 🆚 DVIU 0% 
✔️ 5 years: Optilume® 72% 

Minimally invasive. Drug-coated. Clinically proven. 

💡 Learn more &amp;